Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP26028.RAHzcsEW3SYhA_9Qza41QsLaHUTo1zdqTR3OT_nG88WjY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP26028.RAHzcsEW3SYhA_9Qza41QsLaHUTo1zdqTR3OT_nG88WjY130_assertion type Assertion NP26028.RAHzcsEW3SYhA_9Qza41QsLaHUTo1zdqTR3OT_nG88WjY130_head.
- NP26028.RAHzcsEW3SYhA_9Qza41QsLaHUTo1zdqTR3OT_nG88WjY130_assertion description "[These data suggest that the intravenous administration of pharmacologic doses of rt-PA in patients with pulmonary embolism produces both fibrinolysis and fibrinogenolysis, successful thrombolysis in these patients is associated with a preponderance of fibrinogenolysis over fibrinolysis, the XDP/FDP ratio is a useful indicator of fibrinolytic specificity, and in patients with acute pulmonary embolism the endogenous fibrinolytic pathways are activated, albeit ineffectively, as indicated by the increased circulating XDP levels seen in all 24 patients before the administration of rt-PA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP26028.RAHzcsEW3SYhA_9Qza41QsLaHUTo1zdqTR3OT_nG88WjY130_provenance.
- NP26028.RAHzcsEW3SYhA_9Qza41QsLaHUTo1zdqTR3OT_nG88WjY130_assertion evidence source_evidence_curated NP26028.RAHzcsEW3SYhA_9Qza41QsLaHUTo1zdqTR3OT_nG88WjY130_provenance.
- NP26028.RAHzcsEW3SYhA_9Qza41QsLaHUTo1zdqTR3OT_nG88WjY130_assertion SIO_000772 3105914 NP26028.RAHzcsEW3SYhA_9Qza41QsLaHUTo1zdqTR3OT_nG88WjY130_provenance.
- NP26028.RAHzcsEW3SYhA_9Qza41QsLaHUTo1zdqTR3OT_nG88WjY130_assertion wasDerivedFrom ctd_human-20150221 NP26028.RAHzcsEW3SYhA_9Qza41QsLaHUTo1zdqTR3OT_nG88WjY130_provenance.
- NP26028.RAHzcsEW3SYhA_9Qza41QsLaHUTo1zdqTR3OT_nG88WjY130_assertion wasGeneratedBy ECO_0000218 NP26028.RAHzcsEW3SYhA_9Qza41QsLaHUTo1zdqTR3OT_nG88WjY130_provenance.